WAY100635
WAY100635 Basic information
- Product Name:
- WAY100635
- Synonyms:
-
- Cyclohexanecarboxamide, N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl-, (2Z)-2-butenedioate (1:1)
- WAY-100635 (maleate) N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl-cyclohexanecarboxamide, 2Z-butenedioate
- WAY100635 100MG
- CS-998
- WAY100635 USP/EP/BP
- PectDrill
- Superthiol sirup
- WAY-100635 Monomaleate
- CAS:
- 1092679-51-0
- MF:
- C29H38N4O6
- MW:
- 538.65
- Product Categories:
-
- Inhibitors
- Mol File:
- 1092679-51-0.mol
WAY100635 Chemical Properties
- storage temp.
- Store at -20°C
- solubility
- ≥53.9 mg/mL in DMSO; ≥51.2 mg/mL in EtOH; ≥6.08 mg/mL in H2O with ultrasonic
- form
- solid
- color
- White to off-white
- Water Solubility
- Soluble to 25 mM in water
WAY100635 Usage And Synthesis
Description
WAY-
Uses
WAY-100635 maleate is a potent and selective 5-hydroxytryptamine 1A (5-HT1A) receptor antagonist with an IC50 value of 0.91 nM and Ki value of 0.39 nM. WAY-100635 maleate has pIC50 values for 5-HT1A and α1-adrenergic receptors of 8.9 and 6.6, respectively. WAY-100635 maleate is also a potent dopamine D4 receptor agonist[1][2][3].
in vivo
WAY-100635 (1 mg/kg; subcutaneous injection; male Sprague-Dawley rats) treatment abolishes the reduction of the severity of abstinence signs induced by Rhodiola rosea administration in nicotine-dependent rat[2].
| Animal Model: | Male Sprague-Dawley rats (220-240 g)[2] |
| Dosage: | 1 mg/kg |
| Administration: | Subcutaneous injection (Pharmacokinetic study) |
| Result: | Reduced total abstinence score, increased immobility time and the burying behavior was increased. |
IC 50
D4 Receptor; sPLA2: 8.87 (pIC50); sPLA2: 9.71 (pA2)
storage
Desiccate at RT
References
[1] Chemel BR, et al. WAY-100635 is a potent dopamine D4 receptor agonist. Psychopharmacology (Berl). 2006 Oct;188(2):244-51. DOI:10.1007/s00213-006-0490-4
[2] Mannucci C, et al. Serotonin involvement in Rhodiola rosea attenuation of nicotine withdrawal signs in rats. Phytomedicine. 2012 Sep 15;19(12):1117-24. DOI:10.1016/j.phymed.2012.07.001
[3] Al Hussainy R, et al. Design, synthesis, radiolabeling, and in vitro and in vivo evaluation of bridgehead iodinatedanalogues of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) as potential SPECT ligands for the 5-HT1A receptor. J Med Chem. 2011 May 26;54(10):3480-91. DOI:10.1021/jm1009956
WAY100635Supplier
- Tel
- 18515581800 18501085097
- sales.bj@hwrkchemical.com
- Tel
- 0757-86329057 18934348241
- sales4.gd@hwrkchemical.com
- Tel
- 0411-62910999 13889544652
- sales@meilune.com
- Tel
- 03-36680489
- Sales-JP@TCIchemicals.com
- Tel
- 400-6206333 13167063860
- anhua.mao@aladdin-e.com